SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-040091
Filing Date
2023-11-09
Accepted
2023-11-09 16:56:33
Documents
62
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1418665
2 ex31-1.htm EX-31.1 10848
3 ex31-2.htm EX-31.2 10958
4 ex32-1.htm EX-32.1 5375
5 ex32-2.htm EX-32.2 5160
  Complete submission text file 0001493152-23-040091.txt   6926040

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ensc-20230930.xsd EX-101.SCH 45957
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ensc-20230930_cal.xml EX-101.CAL 51279
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ensc-20230930_def.xml EX-101.DEF 205333
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ensc-20230930_lab.xml EX-101.LAB 395726
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ensc-20230930_pre.xml EX-101.PRE 311573
56 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1209540
Mailing Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037
Business Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037 (858) 263-4196
Ensysce Biosciences, Inc. (Filer) CIK: 0001716947 (see all company filings)

IRS No.: 822755287 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38306 | Film No.: 231393496
SIC: 2834 Pharmaceutical Preparations